Laumonier Hervé, Bioulac-Sage Paulette, Laurent Christophe, Zucman-Rossi Jessica, Balabaud Charles, Trillaud Hervé
Department of Radiology, CHU de Bordeaux, Hopital Saint-André, Bordeaux, France.
Hepatology. 2008 Sep;48(3):808-18. doi: 10.1002/hep.22417.
Hepatocellular adenomas (HCAs) are a group of benign tumors forming three molecular pathological subgroups: (1) hepatocyte nuclear factor 1alpha (HNF-1alpha)-inactivated, (2) beta-catenin-activated, and (3) inflammatory. Some HCAs present both beta-catenin activation and inflammation. We analyzed magnetic resonance imaging (MRI) data for correlations between features on imaging and pathological classification of HCAs. We included 50 cases for which pathology specimens were classified into three groups based on immunohistochemical staining. Two characteristic MRI profiles were identified corresponding to HNF-1alpha-inactivated and inflammatory HCAs. Fifteen HCAs were HNF-1alpha-inactivated. The corresponding lesions showed (1) diffuse signal dropout on T1-weighted chemical shift sequence due to steatosis, (2) isosignal or slight hypersignal on T2-weighted (T2W) images, and (3) moderate enhancement in the arterial phase, with no persistent enhancement in the portal venous and delayed phases. For the diagnosis of HNF-1alpha-inactivated HCA, the positive predictive value of homogeneous signal dropout on chemical shift images was 100%, the negative predictive value was 94.7%, the sensitivity was 86.7%, and the specificity was 100%. Twenty-three HCAs were inflammatory and showed (1) an absence or only focal signal dropout on chemical shift sequence; (2) marked hypersignal on T2W sequences, with a stronger signal in the outer part of the lesions, correlating with sinusoidal dilatation areas; and (3) strong arterial enhancement, with persistent enhancement in the portal venous and delayed phases. Marked hypersignal on T2W sequences associated with delayed persistent enhancement had a positive predictive value of 88.5%, a negative predictive value of 84%, a sensitivity of 85.2%, and a specificity of 87.5% for the diagnosis of inflammatory HCA.
HNF-1alpha-mutated HCAs and inflammatory HCAs were associated with specific MRI patterns related to diffuse fat repartition and sinusoidal dilatation, respectively.
肝细胞腺瘤(HCA)是一组良性肿瘤,形成三个分子病理亚组:(1)肝细胞核因子1α(HNF-1α)失活型,(2)β-连环蛋白激活型,以及(3)炎症型。一些HCA同时存在β-连环蛋白激活和炎症。我们分析了磁共振成像(MRI)数据,以研究成像特征与HCA病理分类之间的相关性。我们纳入了50例病例,其病理标本根据免疫组织化学染色分为三组。识别出两种特征性MRI表现,分别对应于HNF-1α失活型和炎症型HCA。15例HCA为HNF-1α失活型。相应病变表现为:(1)由于脂肪变性,在T1加权化学位移序列上出现弥漫性信号缺失;(2)在T2加权(T2W)图像上呈等信号或轻微高信号;(3)动脉期中等强化,门静脉期和延迟期无持续强化。对于诊断HNF-1α失活型HCA,化学位移图像上均匀信号缺失的阳性预测值为100%,阴性预测值为94.7%,敏感性为86.7%,特异性为100%。23例HCA为炎症型,表现为:(1)化学位移序列上无信号缺失或仅局灶性信号缺失;(2)T2W序列上明显高信号,病变外部信号更强,与窦状隙扩张区域相关;(3)动脉期明显强化,门静脉期和延迟期持续强化。T2W序列上明显高信号伴延迟持续强化对于诊断炎症型HCA的阳性预测值为88.5%,阴性预测值为84%,敏感性为85.2%,特异性为87.5%。
HNF-1α突变型HCA和炎症型HCA分别与弥漫性脂肪分布和窦状隙扩张相关的特定MRI模式有关。